Lupin launches generic joint pain drug in US market

Lupin launches generic joint pain drug in US market

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid

PTIUpdated: Friday, December 09, 2022, 03:17 PM IST
article-image
Image credit: Wikipedia (Representative)

Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.

As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.

RECENT STORIES

Pakistan Faces Twin Risks Of Unrest And Mass Migration As Unemployment Deepens
Pakistan Faces Twin Risks Of Unrest And Mass Migration As Unemployment Deepens
Karur Vysya Bank Expands Footprint With Inauguration Of 900th Branch In Chennai
Karur Vysya Bank Expands Footprint With Inauguration Of 900th Branch In Chennai
Zero-Duty Access For 800–1,600 cc US Motorcycles Under India-US Trade Pact To Boost...
Zero-Duty Access For 800–1,600 cc US Motorcycles Under India-US Trade Pact To Boost...
AEPC Welcomes India-US Trade Framework As Textiles And Apparel Sector Set For Major Export Boost
AEPC Welcomes India-US Trade Framework As Textiles And Apparel Sector Set For Major Export Boost
RCB United? Manchester United Owners Make ₹16,300 Crore Bid For Reigning IPL, WPL Champions As...
RCB United? Manchester United Owners Make ₹16,300 Crore Bid For Reigning IPL, WPL Champions As...